Baxter International Inc., a global leader in medical products, will invest more than E75 million over a six year period of time to introduce new technologies and higher value products to its manufacturing plants in Ireland.
Baxter International Inc. currently owns two manufacturing facilities in Ireland which jointly employee over 1000 people. This investment will expand their operations to introduce new generation manufacturing processes, upgrade existing facilities, and provide for extensive re-skilling of the existing workforce to enhance the production of drug delivery systems.
Baxter International is a global leader in the manufacturing of medical products to assist healthcare professionals and their patients with the treatment of complex medical conditions including hemophilia, immune disorders, kidney disease, cancer, trauma and other conditions. The company developed the first commercially manufactured intravenous (IV) solutions. The company manufactures a line of Baxter Syringe and Infusion Pumps. Popular products include the Baxter Infus O.R. Syringe Pump, the Baxter AS50 Syringe Pump, and the Baxter 6301 Infusion Pump.
